US$ 28.02
contraindications for tirzepatide injection (Zepbound®): Basic information prescribers Tirzepatide for Medical Weight Loss
Description
The Latin America Glucagon-like Peptide-1 (GLP-1) Agonists Market worth USD 2.91 billion in 2026 is growing at a CAGR of 8.24% to reach USD 4.33 billion by 2031

Eating less? Make it count

Prescription GLP-1 physician-supervised weight management & type 2 diabetes care

Learn how this injection works, its benefits, side effects, and whether its right for you.
